Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone adjunct in IVF for women with poor ovarian response
IRCT20241208063979N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of somatotropin in poor ovarian response (POR) and infertility (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Number of follicles, Number of oocytes and 5 more. Started Jun 2025; status: completed.
02
Drugs
somatotropin
03
Conditions
poor ovarian response (POR)infertility
Beyond the preview
Go deeper on IRCT20241208063979N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241208063979N1.